Position in ARGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$45,626,799
+$9,621,095 QoQ
Shares Held
49,179
-0.3% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#70
of 505 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NOMURA ASSET MANAGEMENT CO LTD holds $211,753,525 across 66 Biotechnology names. ARGX ranks #2 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
120,235 | $59,724,331 | |
| 2 | ARGX |
Argenx SE
This page
|
49,179 | $45,626,799 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
88,844 | $26,744,708 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,310 | $26,381,976 | |
| 5 | ASND |
Ascendis Pharma A/S
|
43,678 | $11,649,796 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
51,993 | $9,737,249 | |
| 7 | INCY |
Incyte Corp
|
84,470 | $9,575,518 | |
| 8 | RPRX |
Royalty Pharma plc
|
167,680 | $9,401,817 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,626,799 | 49,179 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $36,005,704 | 49,306 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $41,507,607 | 49,358 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $10,030,815 | 13,600 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,397,719 | 6,164 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,518,888 | 7,635 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,861,595 | 4,653 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,744,146 | 6,907 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $2,970,286 | 6,907 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,249,764 | 8,254 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,235,556 | 8,505 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,997,934 | 8,132 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $2,668,871 | 6,848 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,551,427 | 6,848 | Shares | Sole | 2025-01-10 | |
| 2022-12-31 | $2,594,227 | 6,848 | Shares | Sole | 2025-01-10 | |
| 2022-09-30 | $2,417,686 | 6,848 | Shares | Sole | 2025-01-10 | |
| 2022-06-30 | $2,594,570 | 6,848 | Shares | Sole | 2025-01-10 | |
| 2022-03-31 | $2,159,242 | 6,848 | Shares | Sole | 2025-01-10 | |
| 2021-12-31 | $2,176,430 | 6,215 | Shares | Sole | 2025-01-10 | |
| 2021-09-30 | $1,876,930 | 6,215 | Shares | Sole | 2025-01-10 | |
| 2021-06-30 | $1,673,648 | 5,559 | Shares | Sole | 2025-01-10 | |
| 2021-03-31 | $1,530,893 | 5,559 | Shares | Sole | 2025-01-10 | |
| 2020-12-31 | $0 | 0 | Shares | Sole | 2025-01-10 | |
| 2020-09-30 | $0 | 0 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $0 | 0 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $0 | 0 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||